Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Marker, Biological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00376233
What this trial is testing

Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia

Who this might be right for
SchizophreniaCannabis Abuse
University of Jena 100
Not applicableStudy completedNCT02917811
What this trial is testing

Red Cell Distribution Width (RDW) as a Prognostic Marker in ICU

Who this might be right for
Blood TransfusionBiochemical Marker
Università degli Studi di Ferrara 250
Testing effectiveness (Phase 2)Study completedNCT02076711
What this trial is testing

Myocardial Efficiency of the Left Ventricle in Asymptomatic Patients With Aortic Valve Stenosis - a Prognostic Marker and a Target for Intervention?

Who this might be right for
Aortic Stenosis
Aarhus University Hospital 40
Not applicableStudy completedNCT06607809
What this trial is testing

Inflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCC

Who this might be right for
Metastatic Renal Cell Carcinoma
Dr. Lutfi Kirdar Kartal Training and Research Hospital 99
Early research (Phase 1)Study completedNCT02783599
What this trial is testing

Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eli Lilly and Company 51
Not applicableUnknownNCT04071067
What this trial is testing

Anemia of Inflammation and Deficiency Anemia

Who this might be right for
Anemia, Iron DeficiencyAnemia of Chronic Disease
Iuliu Hatieganu University of Medicine and Pharmacy 1,000
Early research (Phase 1)Study completedNCT01608009
What this trial is testing

[18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer

Who this might be right for
Ovarian Neoplasm
Imperial College London 16
Not applicableLooking for participantsNCT06481878
What this trial is testing

Validation of an Alzheimer's Disease Marker by Fecal Assay of Amyloid Peptides and Tau Proteins

Who this might be right for
Alzheimer Disease
University Hospital, Grenoble 115
Testing effectiveness (Phase 2)Study completedNCT02664935
What this trial is testing

National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerCarcinoma, Squamous CellAdenocarcinoma
University of Birmingham 423
Post-approval studies (Phase 4)Study completedNCT00460057
What this trial is testing

The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss

Who this might be right for
Osteoporosis
Eulji University Hospital 63
Testing effectiveness (Phase 2)Ended earlyNCT06405230
What this trial is testing

Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 2
Not applicableStudy completedNCT06850415
What this trial is testing

Validation of New Type Radiopaque Marker in The Evaluation of Colonic Transit Time

Who this might be right for
Slow Transit ConstipationColonic TransitChronic Constipation+2 more
Mahidol University 20
Not applicableActive Not RecruitingNCT02194738
What this trial is testing

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Who this might be right for
Stage IB Lung Non-Small Cell Carcinoma AJCC v7Stage II Lung Non-Small Cell Cancer AJCC v7Stage IIA Lung Cancer AJCC v8+4 more
National Cancer Institute (NCI) 7,458
Testing effectiveness (Phase 2)WithdrawnNCT00374517
What this trial is testing

Pimonidazole Hydrochloride to Detect Low Oxygen in Tuberculosis-Infected Lungs

Who this might be right for
Refractory Pulmonary Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT02455089
What this trial is testing

Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus
University Hospital, Grenoble 143
Not applicableWithdrawnNCT05256368
What this trial is testing

Marker for Stroke Recovery

Who this might be right for
Stroke, Ischemic
Shirley Ryan AbilityLab
Not applicableStudy completedNCT00932061
What this trial is testing

Developing Biomarkers for Fibromyalgia

Who this might be right for
Fibromyalgia
University of Michigan 105
Not applicableLooking for participantsNCT05592886
What this trial is testing

A Novel Oral Synbiotic Formula in Reducing Advanced Adenoma Recurrence and Colorectal Neoplasia-related Bacterial Gene Markers

Who this might be right for
Colorectal NeoplasmsColorectal AdenomaColorectal Cancer+1 more
Chinese University of Hong Kong 649
Not applicableStudy completedNCT04625088
What this trial is testing

Identification of Biometric Marker(s) Capable of Detecting Early Prediabetes: Clinical Trial 1

Who this might be right for
Healthy
SciMar Ltd. 24
Not applicableStudy completedNCT03814603
What this trial is testing

The Sleep Amyloid, Slow WAve Race and Ethnicity Study

Who this might be right for
Alzheimer Disease
NYU Langone Health 210
Next Page